Discover Mental Health
May 25, 2026
Filip Blazek, Klara Latalova, David Krahulik et al.
Psychedelic-assisted therapy and neurostimulation represent converging approaches to modulating dysfunctional brain circuits in treatment-resistant psychiatric disorders. This Perspective outlines shared mechanisms involving neuroplasticity and network reconfiguration, and examines ethical, regulatory, and infrastructural barriers to their translation. Bridging neuroscience, psychiatry, and...
Discover Mental Health
May 25, 2026
M. Iravani, Shahla Molavi, Saeed Ghanbari et al.
Pregnancy is accompanied by numerous physical and psychological changes that can affect sexual quality of life and increase sexual distress in women. Identifying effective interventions to address these issues is essential. This study aimed to evaluate the effect of mindfulness-based cognitive-behavioral therapy on sexual distress and sexual quality of life in pregnant women. In this...
Discover Mental Health
April 11, 2026
Yu Gao, Liat Zitron, Serena Guo
Mindfulness-based interventions (MBIs) have been consistently associated with reductions in perceived stress and anxiety. One proposed mechanism underlying these effects involves a shift toward parasympathetic dominance during stress exposure, facilitating enhanced emotion regulation and physiological adaptability; however, empirical evidence on this mechanism remains inclusive. In this...
Discover Mental Health
March 21, 2026
Martha Newson, Leor Roseman, S. Alexander Haslam
Recent advances in psychedelic-assisted therapies highlight their efficacy in treating various mental health conditions. Nevertheless, the fact that delivery is generally individualised may limit therapeutic outcomes by failing to capitalise on opportunities to build and harness a sense of shared social identity among participants in ways hypothesised by ‘social cure’ research. In line with...
Discover Mental Health
March 19, 2026
Àlvar Farré-colomés, Olga Rublinetska, Oscar Soto-Angona
Psilocybin-assisted therapies are innovative therapeutic approaches, particularly in the treatment of depression. However, there are sparse studies providing functional magnetic resonance imaging (fMRI) evidence elucidating the underlying biological mechanisms that support clinical outcomes. This review aims to comprehensively gather all the evidence reported in psilocybin studies using fMRI...
Discover Mental Health
March 7, 2026
Nicholas Fabiano, Brendon Stubbs, David W. Lawrence et al.
Upwards of 50% of people do not respond to the primary treatment modalities for major depressive disorder (MDD), which has led to increased attention and use of alternative methods, including exercise and psychedelics. While interventions using either exercise or psychedelics have demonstrated largely positive results in isolation, their synergistic potential has yet to be explored. As such,...
Discover Mental Health
January 8, 2026
Mireya Velázquez-Paniagua, Laura Gómez-Virgilio, Blanca Margarita Gómez-Chavarín et al.
INTRODUCTION: In Mexico, 25–45% of medical students experience burnout syndrome, which may be reduced through mindfulness-based interventions (MBI). No study has evaluated this intervention’s impact on our country’s population. Therefore, this study aimed to determine the effects of an eight-week MBI on medical students, professors and administrative staff from the Faculty of Medicine at the...
Discover Mental Health
November 16, 2025
Saranya Ts, Kiniholi Yepthomi
1 citation
Abstract This systematic review examines how cultural constructs of distress and the phenomenon of lycanthropy are understood within the context of Nagaland, emphasizing a social constructivist framework. A comprehensive literature search was conducted across Google Scholar, PubMed, and PsycINFO, ultimately shortlisting 24 methodologically sound studies relevant to cultural interpretations of...
Discover Mental Health
April 8, 2025
Isabel Wießner, Júlia Paula Souza, Marcelo Demarzo et al.
3 citations
Mindfulness improves mental health and clinical conditions including psychosis and modulates attentional processes including salience-the automatic direction of attention to prominent elements. Aberrant salience-the exaggerated significance attribution to perceived elements-is associated with psychotic experiences, but its interactions with mindfulness remain unexplored. This...
Discover Mental Health
September 17, 2024
S K Spoelstra, Robert A Schoevers, S D Venema et al.
8 citations
Despite considerable efforts, tobacco use disorder persists as a significant public health issue. The effectiveness of current smoking cessation therapies is limited, leading to a growing interest in alternative treatment approaches such as psychedelics. The aim of this review is to evaluate the scientific evidence regarding the role of psychedelics in smoking cessation. To identify relevant...
Discover Mental Health
July 1, 2024
Keshav Juneja, Sabah Afroze, Zeel Goti et al.
6 citations
Ketamine, a pharmacological agent that acts as an antagonist of the N-methyl-D-aspartate (NMDA) receptor, has garnered considerable interest because of its notable and expeditious antidepressant properties observed in individuals diagnosed with major depressive disorder (MDD) who exhibit resistance to conventional therapeutic interventions. A comprehensive and rigorous systematic review was...
Discover Mental Health
May 28, 2024
Joshua G. Kovoor, Sanjana Santhosh, Brandon Stretton et al.
4 citations
Background This scoping review aimed to characterise near-death experiences in the setting of cardiac arrest, a phenomenon that is poorly understood and may have clinical consequences. Method PubMed/MEDLINE was searched to 23 July 2023 for prospective studies describing near-death experiences in cardiac arrest. PRISMA-ScR guidelines were adhered to. Qualitative and quantitative data were...
Discover Mental Health
April 17, 2024
Jon Berner, Animesh Acharjee
7 citations
Depression is a disorder with variable presentation. Selecting treatments and dose-finding is, therefore, challenging and time-consuming. In addition, novel antidepressants such as ketamine have sparse optimization evidence. Insights obtained from metabolomics may improve the management of patients. The objective of this study was to determine whether compounds in the cerebrospinal fluid (CSF)...
Discover Mental Health
April 15, 2022
Mani Yavi, Holim Lee, Ioline D. Henter et al.
150 citations
-enantiomer, intranasal esketamine, for the treatment of major depressive disorder (MDD). Initial studies found that a single subanesthetic-dose IV ketamine infusion rapidly (within one day) improved depressive symptoms in individuals with MDD and bipolar depression, with antidepressant effects lasting three to seven days. In 2019, esketamine received FDA approval as an adjunctive treatment for...